MSD United Kingdom
UK affiliate of a global biopharmaceutical company conducting interdisciplinary early discovery across chemistry, pharmacology, neuroscience and immunology; sponsoring and operating clinical studies in the UK; and partnering with NHS organisations and academic centres on clinical pathway optimisation, service redesign and public‑health programmes. Examples include regional capacity and demand modelling for systemic anti‑cancer therapy (SACT), clinical pathway development for skin cancer, co‑design of local vaccine delivery models, deployment of digital patient engagement and pre‑assessment tools, pathology and MDT pathway optimisation, and laboratory sustainability initiatives.
Industries
N/A
Products
Human medicines and vaccines
Research‑driven portfolio of prescription medicines and vaccines across multiple therapeutic areas for prevention and treatment of disease.
Veterinary medicines and services
Development, manufacture and marketing of veterinary products and services for farm and companion animals.
Educational reports, infographics and policy documents
Published resources including health‑economics infographics, policy consensus statements and case‑study reports to inform practice and policy.
Human medicines and vaccines
Research‑driven portfolio of prescription medicines and vaccines across multiple therapeutic areas for prevention and treatment of disease.
Veterinary medicines and services
Development, manufacture and marketing of veterinary products and services for farm and companion animals.
Educational reports, infographics and policy documents
Published resources including health‑economics infographics, policy consensus statements and case‑study reports to inform practice and policy.
Services
Clinical trial sponsorship and operations
Design and execution of company‑sponsored clinical studies with site engagement, monitoring and safety oversight.
SACT demand and capacity modelling and implementation
Provision of capacity‑modelling analyses, facilitated workshops, dashboards and follow‑up evaluation to inform trust and cancer‑alliance action plans for systemic anti‑cancer therapy delivery.
Clinical pathway development and implementation (skin cancer case example)
Project‑based pathway mapping, gap analysis, implementation support and measurement to optimise incidental skin cancer referral and treatment pathways. A regional example delivered updated referral processes and measured improvements in treatment performance metrics.
Pathology and diagnostic pathway development
Pathway mapping, gap analysis and implementation support for histopathology and molecular testing to reduce turnaround times and enable appropriate in‑house testing.
Virtual pre‑assessment and remote patient assessment services
Implementation and evaluation of virtual pre‑assessment pathways using mobile/web platforms to release clinical capacity and improve patient experience.
Digital patient engagement and diagnostic activation
Co‑design and deployment of symptom‑checkers, self‑referral tools, healthbots and ePROM platforms to increase service uptake and capture patient experience data.
Clinical trial sponsorship and operations
Design and execution of company‑sponsored clinical studies with site engagement, monitoring and safety oversight.
SACT demand and capacity modelling and implementation
Provision of capacity‑modelling analyses, facilitated workshops, dashboards and follow‑up evaluation to inform trust and cancer‑alliance action plans for systemic anti‑cancer therapy delivery.
Clinical pathway development and implementation (skin cancer case example)
Project‑based pathway mapping, gap analysis, implementation support and measurement to optimise incidental skin cancer referral and treatment pathways. A regional example delivered updated referral processes and measured improvements in treatment performance metrics.
Pathology and diagnostic pathway development
Pathway mapping, gap analysis and implementation support for histopathology and molecular testing to reduce turnaround times and enable appropriate in‑house testing.
Virtual pre‑assessment and remote patient assessment services
Implementation and evaluation of virtual pre‑assessment pathways using mobile/web platforms to release clinical capacity and improve patient experience.
Digital patient engagement and diagnostic activation
Co‑design and deployment of symptom‑checkers, self‑referral tools, healthbots and ePROM platforms to increase service uptake and capture patient experience data.
Expertise Areas
- Drug discovery and early‑stage translational research
- Structural biology and cellular imaging
- Clinical trial operations and sponsorship
- Clinical data integration and clinician dashboard deployment
Key Technologies
- Capacity and demand modelling tools for healthcare services
- Service performance dashboards and reporting
- Time‑and‑motion observational methods
- Virtual pre‑assessment and digital patient engagement platforms